Miller Family Wine Company and RNDC Announce New National Partnership
SANTA BARBARA, Calif., April 4, 2024 /PRNewswire/ — Miller Family Wine Company (MFWC), owned by one of California’s premier winegrowing families, is pleased to announce its national partnership with Republic National Distributing Company (RNDC), effective April 2, 2024. MFWC is known f
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Ocugen, Inc. – OCGN
NEW YORK, April 4, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Katapult Holdings, Inc. – KPLT
NEW YORK, April 4, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Katapult Holdings, Inc. (“Katapult” or the “Company”) (NASDAQ: KPLT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, e
Berger Montague Announces that its False Claims Act Whistleblower Case Against CVS Health Will Move Forward to Trial
PHILADELPHIA, April 4, 2024 /PRNewswire/ — Berger Montague PC is pleased to announce that its False Claims Act whistleblower case against CVS Caremark Corp. (including its pharmacy benefit manager subsidiary, CVS Caremark) for false drug pricing to Medicare will move forward to trial. In a d
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against bluebird bio, Inc. – BLUE
NEW YORK, April 4, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against bluebird bio, Inc. (“bluebird” or the “Company”) (NASDAQ: BLUE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-5
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. – ZVRA
NEW YORK, April 4, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Zevra Therapeutics, Inc. (“Zevra” or the “Company”) (NASDAQ: ZVRA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext
Norfolk Southern announces new initiatives to drive further productivity and accountability
Executive compensation plan adjustments address shareholder feedback and hold management accountable to deliver on key objectives ATLANTA, April 4, 2024 /PRNewswire/ — Norfolk Southern Corporation (NYSE: NSC) provided an update Thursday on its plan to accelerate progress on its strategy and d
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DraftKings Inc. – DKNG
NEW YORK, April 4, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of DraftKings Inc. (“DraftKings” or the “Company”) (NASDAQ: DKNG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Comtech Telecommunications Corp. – CMTL
NEW YORK, April 4, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Comtech Telecommunications Corp. (“Comtech” or the “Company”) (NASDAQ: CMTL). Such investors are advised to contact Danielle Peyton at [email protected] or 646
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar Medical Holding Corporation – ICU
NEW YORK, April 4, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of SeaStar Medical Holding Corporation (“SeaStar” or the “Company”) (NASDAQ: ICU). Such investors are advised to contact Danielle Peyton at [email protected] or 646